What is CareSignal?
CareSignal is a health technology firm specializing in enhancing performance within value-based care frameworks. The company achieves this through standardized, automated patient engagement, with a particular focus on real-time identification of patients exhibiting rising health risks. Its deviceless remote patient monitoring solutions are engineered for value-based care organizations, providing accessible and cost-effective services. CareSignal supports a broad spectrum of clients, including self-insured commercial entities, Medicaid programs, and payer organizations, all aimed at improving patient engagement and overall health outcomes. The company's technology and support infrastructure are designed to bolster proactive care strategies and elevate population health metrics.
How much funding has CareSignal raised?
CareSignal has raised a total of $765K across 1 funding round:
Debt
$765K
Debt (2015): $765K with participation from BioGenerator
Key Investors in CareSignal
BioGenerator
BioGenerator is an organization focused on supporting and investing in the life sciences sector, likely providing strategic capital and resources to companies developing innovative healthcare technologies.
What's next for CareSignal?
The substantial enterprise-level funding indicates CareSignal is poised for significant scaling and further development of its remote patient monitoring capabilities. This strategic capital infusion will likely fuel expansion into new markets, enhance its technological infrastructure, and deepen its partnerships with value-based care providers. The company's focus on automated patient engagement and risk identification positions it to capitalize on the growing shift towards value-based reimbursement models, suggesting a trajectory of sustained growth and market leadership in proactive healthcare solutions.
See full CareSignal company page
